Education
About Us
Working with TipRanks
Follow Us
Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP)
LSE:BXP
BXP Stock Chart & Stats
Day’s Range― - ―
52-Week Range19.33p - 42.00p
Previous CloseN/A
Volume9.88K
Average Volume (3M)24.97K
Market Cap
$40.73B
Enterprise Value225.90M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)8.94B
Price to Earnings (P/E)4.2
Beta0.42
Next Earnings
May 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 22, 2024Dividend Yield5.35%
Share Statistics
EPS (TTM)0.10
Shares Outstanding446,112,100
10 Day Avg. Volume10,077
30 Day Avg. Volume24,966
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Beximco Pharmaceuticals Limited Sponsored GDR RegS News
PremiumCompany Announcements
Beximco Pharma Denies Corruption Allegations in Vaccine Procurement
PremiumCompany Announcements
Beximco Pharmaceuticals Faces Board Restructuring Amid Legal Proceedings
PremiumCompany Announcements
Beximco Pharma Awaits Court Decision on Board Appointments
PremiumCompany Announcements
Beximco Pharmaceuticals Declares 40% Cash Dividend for 2024
PremiumCompany Announcements
Beximco Pharma Announces New Board AppointmentPremiumCompany Announcements
Beximco Pharma’s Board Restructuring Challenged in Court---
BXP FAQ
What was Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price range in the past 12 months?
Beximco Pharmaceuticals Limited Sponsored GDR RegS lowest share price was 19.32p and its highest was 42.00p in the past 12 months.
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s market cap is $40.73B.
When is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s upcoming earnings report date is May 06, 2025 which is in 4 days.
How were Beximco Pharmaceuticals Limited Sponsored GDR RegS’s earnings last quarter?
Beximco Pharmaceuticals Limited Sponsored GDR RegS released its earnings results on Jan 29, 2025. The company reported 0.027p earnings per share for the quarter, beating the consensus estimate of N/A by 0.027p.
Is Beximco Pharmaceuticals Limited Sponsored GDR RegS overvalued?
According to Wall Street analysts Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price is currently Overvalued.
Does Beximco Pharmaceuticals Limited Sponsored GDR RegS pay dividends?
Beximco Pharmaceuticals Limited Sponsored GDR RegS pays a Annually dividend of 2.078p which represents an annual dividend yield of 5.35%. See more information on Beximco Pharmaceuticals Limited Sponsored GDR RegS dividends here
What is Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate?
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beximco Pharmaceuticals Limited Sponsored GDR RegS have?
Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding.
What happened to Beximco Pharmaceuticals Limited Sponsored GDR RegS’s price movement after its last earnings report?
Beximco Pharmaceuticals Limited Sponsored GDR RegS reported an EPS of 0.027p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Beximco Pharmaceuticals Limited Sponsored GDR RegS?
Currently, no hedge funds are holding shares in GB:BXP
---
Beximco Pharmaceuticals Limited Sponsored GDR RegS Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.06%
12-Months-Change
Fundamentals
Return on Equity
13.12%
Trailing 12-Months
Asset Growth
-2.31%
Trailing 12-Months
Company Description
Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
---
Technical Analysis
---